Abstract:Photodynamic therapy (PDT) using two-photon near-infrared light excitation is a very effective way to avoid the use of short-wavelength ultraviolet or visible light which cannot efficiently penetrate into the biological tissues and is harmful to the healthy cells. Herein, a series of cyclometalated Ir(III) complexes with a structurally simple diimine ligand were designed and the synthetic route and preparation procedure were optimized, so that the complexes could be obtained in apparently higher yield, productivity, and efficiency in comparison to the traditional methods. Their ground state and excited singlet and triplet state properties were studied by spectroscopy and quantum chemistry theoretical calculations to investigate the effect of substituent groups on the photophysical properties of the complexes. The Ir(III) complexes, especially Ir1 and Ir3, showed very low dark toxicities and high phototoxicities under both one-photon and two-photon excitation, indicating their great potential as PDT agents. They were also found to be highly sensitive two-photon mitochondria dyes.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.inorgchem.0c01509?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.inorgchem.0c01509</a>.Optimized structures and frontier molecular orbitals, simulated and experimental electronic absorption spectra, cyclic voltammetry, emission spectra in aqueous solution, time-dependent changes in absorption spectra of DPBF in the presence of Ir(III) complexes, Pearson's correlation coefficient (R) analysis (PCCA) between Ir(III) complexes and MTG by CLSM on human cancer cells A549, Z-stack images of A549 stained by Ir(III) complexes, DNA-binding experiments, and experimental and computational absorption spectral data and Cartesian coordinates of the optimized structures of Ir(III) complexes for S0, S1, and T1 states (<a class="ext-link" href="/doi/suppl/10.1021/acs.inorgchem.0c01509/suppl_file/ic0c01509_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

An Iridium(iii)-Palladium(ii) Metal-Organic Cage for Efficient Mitochondria-Targeted Photodynamic Therapy

Cyclometalated Ir(III) Complexes as Mitochondria-Targeted Photodynamic Anticancer Agents

Cyclometalated iridium(iii) complex nanoparticles for mitochondria-targeted photodynamic therapy

Photodecaging of a Mitochondria-Localized Iridium(III) Endoperoxide Complex for Two-Photon Photoactivated Therapy under Hypoxia

Highly effective self-assembled porphyrin MOCs nanomaterials for enhanced photodynamic therapy in tumor

Cyclometalated Iridium(III) Complexes as High-Sensitivity Two-Photon Excited Mitochondria Dyes and Near-Infrared Photodynamic Therapy Agents

Metalloporphyrin–indomethacin conjugates as new photosensitizers for photodynamic therapy

A Mitochondria Targeting Ir(III) Complex Triggers Ferroptosis and Autophagy for Cancer Therapy: A Case of Aggregation Enhanced PDT Strategy for Metal Complexes

Cyclometalated iridium(III) tetrazine complexes for mitochondria-targeted two-photon photodynamic therapy

A photoactive Ir–Pd bimetallic cage with high singlet oxygen yield for efficient one/two-photon activated photodynamic therapy

Mitochondria-localized Iridium(iii) Complexes with Anthraquinone Groups As Effective Photosensitizers for Photodynamic Therapy under Hypoxia

Electrostatic Self-Assembled Iridium(III) Nano-Photosensitizer for Selectively Disintegrated and Mitochondria Targeted Photodynamic Therapy

Synthesis, Photophysical and Anticancer Properties of Mitochondria-Targeted Phosphorescent Cyclometalated Iridium(iii) N-heterocyclic Carbene Complexes.

Mitochondrial‐DNA‐Targeted IrIII‐Containing Metallohelices with Tunable Photodynamic Therapy Efficacy in Cancer Cells

A Mitochondrion-Targeted BODIPY-Ir(III) Conjugate As a Photoinduced ROS Generator for the Oxidative Destruction of Triple-Negative Breast Cancer Cells.

Aggregation-induced emission-active iridium (III)-based mitochondria-targeting nanoparticle for two-photon imaging-guided photodynamic therapy

AIPE-Active Ir(III) Complexes with Tuneable Photophysical Properties and Application in Mitochondria-Targeted Dual-Mode Photodynamic Therapy.

Engineering of Upconversion Carbon Dots/Metal-Organic Frameworks “Peeled Pitaya-Like” Heterostructure for Mitochondria-Targeted Photodynamic Therapy

Phosphorescent Iridium(iii)-Bis-n-heterocyclic Carbene Complexes As Mitochondria-Targeted Theranostic and Photodynamic Anticancer Agents.

Mitochondrion-targeting Chemiluminescent Ternary Supramolecular Assembly for in Situ Photodynamic Therapy.

Biotin-modified Cyclometalated Iridium-Based Photosensitizers As Mitochondria-Targeted Theranostic Agents for Tumor Photodynamic Therapy in Vitro and in Vivo